Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherShort-Term Debt repayments
Ratios

Abvc Biopharma (ABVC) Long-Term Debt Issuances (2018 - 2025)

Abvc Biopharma (ABVC) has disclosed Long-Term Debt Issuances for 9 consecutive years, with $490000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Issuances rose 716.67% year-over-year to $490000.0, compared with a TTM value of $499010.0 through Dec 2025, up 45.87%, and an annual FY2025 reading of $499010.0, up 45.87% over the prior year.
  • Long-Term Debt Issuances was $490000.0 for Q4 2025 at Abvc Biopharma, up from -$37329.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $3.2 million in Q1 2023 and bottomed at -$1.8 million in Q3 2023.
  • Average Long-Term Debt Issuances over 4 years is $230929.5, with a median of $64114.0 recorded in 2024.
  • Peak annual rise in Long-Term Debt Issuances hit 716.67% in 2025, while the deepest fall reached 158.22% in 2025.
  • Year by year, Long-Term Debt Issuances stood at $236498.0 in 2021, then crashed by 53.44% to $110110.0 in 2023, then tumbled by 45.51% to $60000.0 in 2024, then skyrocketed by 716.67% to $490000.0 in 2025.
  • Business Quant data shows Long-Term Debt Issuances for ABVC at $490000.0 in Q4 2025, -$37329.0 in Q2 2025, and $46339.0 in Q1 2025.